Franklin Resources Inc Vertex Pharmaceuticals Inc Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Franklin Resources Inc holds 476,833 shares of VRTX stock, worth $195 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

476,833

Previous 476,833 -0.0%

Holding current value

$195 Million

Previous $222 Million -0.0%

% of portfolio

0.07%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $34.8 Million - $38.2 Million	-75,581 Reduced 13.68%	476,833 $222 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $59.2 Million - $73.1 Million	-150,645 Reduced 21.43%	552,414 $259 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $12.5 Million - $13.7 Million	30,621 Added 4.55%	703,059 $294 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $28.2 Million - $33.7 Million	-82,086 Reduced 10.88%	672,438 $274 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $26 Million - $27.9 Million	-77,014 Reduced 9.26%	754,524 $262 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $21.3 Million - $23.8 Million	67,629 Added 8.85%	831,538 $293 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $7.95 Million - $9.07 Million	-28,066 Reduced 3.54%	763,909 $241 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $40.3 Million - $45.3 Million	-140,876 Reduced 15.1%	791,975 $229 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $15.9 Million - $17.8 Million	-58,108 Reduced 5.86%	932,851 $270 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $31.4 Million - $39.1 Million	-133,797 Reduced 11.9%	990,959 $279 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $14.5 Million - $17.1 Million	65,455 Added 6.18%	1,124,756 $294 Million
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $34.1 Million - $43 Million	192,377 Added 22.19%	1,059,301 $233 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $45.6 Million - $51 Million	-251,473 Reduced 22.49%	866,924 $157 Million
Q2 2021 Aug 13, 2021	SELL	$187.49 - $221.1 $8.49 Million - $10 Million	-45,280 Reduced 3.89%	1,118,397 $226 Million
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $24.1 Million - $28.1 Million	-116,400 Reduced 9.09%	1,163,677 $250 Million
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $17.8 Million - $23.8 Million	86,217 Added 7.22%	1,280,077 $303 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $13.1 Million - $15.5 Million	51,163 Added 4.48%	1,193,860 $325 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $11.5 Million - $15.1 Million	50,902 Added 4.66%	1,142,697 $333 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $11 Million - $13.7 Million	-55,194 Reduced 4.81%	1,091,795 $260 Million
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $16.8 Million - $22.6 Million	-100,879 Reduced 8.08%	1,146,989 $251 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $28.4 Million - $31.9 Million	170,686 Added 15.85%	1,247,868 $211 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $13.7 Million - $15.8 Million	-82,941 Reduced 7.15%	1,077,182 $198 Million
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $8.74 Million - $10.4 Million	-53,371 Reduced 4.4%	1,160,123 $213 Million
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $3.41 Million - $4.31 Million	-22,441 Reduced 1.82%	1,213,494 $201 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $9.19 Million - $10.6 Million	-54,820 Reduced 4.25%	1,235,935 $238 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $23.9 Million - $27.8 Million	163,689 Added 14.52%	1,290,755 $219 Million
Q1 2018 May 10, 2018	SELL	$151.6 - $177.13 $18.8 Million - $22 Million	-123,926 Reduced 9.91%	1,127,066 $184 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $12.5 Million - $14.2 Million	91,078 Added 7.85%	1,250,992 $187 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $172 Million - $188 Million	1,159,914	1,159,914 $176 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Vertex Pharmaceuticals Inc Transaction History